Biodexa Pharmaceuticals plc
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Biodexa Pharmaceuticals plc now
Current reporting with the operating signal separated from the noise.
Biodexa Pharmaceuticals PLC (BDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates
Investors are testing whether Biodexa Pharmaceuticals plc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biodexa Pharmaceuticals PLC: Result of General Meeting
The story matters when it changes Biodexa Pharmaceuticals plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biodexa Pharmaceuticals plc Revenue Breakdown – NASDAQ:BDRX
Investors are testing whether Biodexa Pharmaceuticals plc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biodexa Pharmaceuticals PLC: ADR Ratio Change
The story matters when it changes Biodexa Pharmaceuticals plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Regains Compliance For Continued Listing on Nasdaq
The development tests whether Biodexa Pharmaceuticals plc can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Biodexa Pharmaceuticals PLC Announces Exercise of Pre-Funded Warrants & Issue of Equity
The story matters when it changes Biodexa Pharmaceuticals plc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest BDRX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Biodexa Pharmaceuticals plc, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →